{"id":"https://openalex.org/W4281611909","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101","title":"A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).","display_name":"A phase 1 study of AMG 509 in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281611909","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.tps5101","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036310901","display_name":"Daniel Costin Danila","orcid":"https://orcid.org/0000-0002-7647-0741","observed_orcids":["https://orcid.org/0000-0002-7647-0741"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Costin Danila","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053359739","display_name":"David Michael Waterhouse","orcid":"https://orcid.org/0000-0001-5589-9939","observed_orcids":["https://orcid.org/0000-0001-5589-9939"]},"institutions":[{"id":"https://openalex.org/I4210153992","display_name":"Oncology Hematology Care","ror":"https://ror.org/04gqr8882","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210153992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Michael Waterhouse","raw_affiliation_strings":["US Oncology Research/Oncology Hematology Care (OHC), Inc., Cincinnati, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research/Oncology Hematology Care (OHC), Inc., Cincinnati, OH;","institution_ids":["https://openalex.org/I4210153992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012316179","display_name":"Leonard Joseph Appleman","orcid":"https://orcid.org/0000-0003-4951-7388","observed_orcids":["https://orcid.org/0000-0003-4951-7388"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]},{"id":"https://openalex.org/I4210134769","display_name":"University of Pittsburgh Medical Center","ror":"https://ror.org/04ehecz88","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210098814","https://openalex.org/I4210134769"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leonard Joseph Appleman","raw_affiliation_strings":["University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526","https://openalex.org/I4210134769"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090641762","display_name":"David William Pook","orcid":"https://orcid.org/0000-0002-1744-3022","observed_orcids":["https://orcid.org/0000-0002-1744-3022"]},"institutions":[{"id":"https://openalex.org/I4210121067","display_name":"Monash Health","ror":"https://ror.org/02t1bej08","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"David William Pook","raw_affiliation_strings":["Monash Health, Melbourne, VIC, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash Health, Melbourne, VIC, Australia;","institution_ids":["https://openalex.org/I4210121067"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014625956","display_name":"Nobuaki Matsubara","orcid":"https://orcid.org/0000-0002-9203-4245","observed_orcids":["https://orcid.org/0000-0002-9203-4245"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobuaki Matsubara","raw_affiliation_strings":["National Cancer Center Hospital East, Chiba, Japan;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center Hospital East, Chiba, Japan;","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091696839","display_name":"Tanya Barauskas Dorff","orcid":"https://orcid.org/0000-0001-5990-298X","observed_orcids":["https://orcid.org/0000-0001-5990-298X"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tanya B. Dorff","raw_affiliation_strings":["City of Hope Comprehensive Cancer Center, Duarte, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Comprehensive Cancer Center, Duarte, CA;","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063838757","display_name":"Jae\u2010Lyun Lee","orcid":"https://orcid.org/0000-0002-9420-7162","observed_orcids":["https://orcid.org/0000-0002-9420-7162"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]},{"id":"https://openalex.org/I40542001","display_name":"University of Ulsan","ror":"https://ror.org/02c2f8975","country_code":"KR","type":"education","lineage":["https://openalex.org/I40542001"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jae-Lyun Lee","raw_affiliation_strings":["Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I2801680663","https://openalex.org/I40542001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038489185","display_name":"Andrew J. Armstrong","orcid":"https://orcid.org/0000-0001-7012-1754","observed_orcids":["https://orcid.org/0000-0001-7012-1754"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},{"id":"https://openalex.org/I4210126298","display_name":"Duke Medical Center","ror":"https://ror.org/03njmea73","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876"]},{"id":"https://openalex.org/I4390039326","display_name":"Duke Cancer Institute","ror":"https://ror.org/04vt65461","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210126298","https://openalex.org/I4210144876","https://openalex.org/I4390039326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew J. Armstrong","raw_affiliation_strings":["Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University School of Medicine, Durham, NC;","institution_ids":["https://openalex.org/I170897317","https://openalex.org/I4210126298","https://openalex.org/I4390039326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100726133","display_name":"Miso Kim","orcid":"https://orcid.org/0000-0002-4064-4199","observed_orcids":["https://orcid.org/0000-0002-4064-4199"]},"institutions":[{"id":"https://openalex.org/I139264467","display_name":"Seoul National University","ror":"https://ror.org/04h9pn542","country_code":"KR","type":"education","lineage":["https://openalex.org/I139264467"]},{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Miso Kim","raw_affiliation_strings":["Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea;","institution_ids":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084855225","display_name":"Lisa Glen Horvath","orcid":"https://orcid.org/0000-0001-6842-9223","observed_orcids":["https://orcid.org/0000-0001-6842-9223"]},"institutions":[{"id":"https://openalex.org/I4210093547","display_name":"Chris O\u2019Brien Lifehouse","ror":"https://ror.org/00qeks103","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210093547"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Lisa Horvath","raw_affiliation_strings":["Chris O'Brien Lifehouse, Sydney, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chris O'Brien Lifehouse, Sydney, Australia;","institution_ids":["https://openalex.org/I4210093547"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016875639","display_name":"Christopher Joseph Sumey","orcid":"https://orcid.org/0000-0002-9288-2236","observed_orcids":["https://orcid.org/0000-0002-9288-2236"]},"institutions":[{"id":"https://openalex.org/I1305840828","display_name":"Sanford Health","ror":"https://ror.org/003smky23","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1305840828"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Joseph Sumey","raw_affiliation_strings":["Sanford Cancer Center, Sioux Falls, SD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sanford Cancer Center, Sioux Falls, SD;","institution_ids":["https://openalex.org/I1305840828"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008955600","display_name":"Freda Cooner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Freda Cooner","raw_affiliation_strings":["AmgenInc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AmgenInc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079285446","display_name":"Mark Salvati","orcid":"https://orcid.org/0000-0002-4058-7366","observed_orcids":["https://orcid.org/0000-0002-4058-7366"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Salvati","raw_affiliation_strings":["Amgen Inc., Thousand Oaks, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc., Thousand Oaks, CA;","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058424325","display_name":"Julia Stieglmaier","orcid":"https://orcid.org/0009-0009-7035-5855","observed_orcids":["https://orcid.org/0009-0009-7035-5855"]},"institutions":[{"id":"https://openalex.org/I4210121112","display_name":"Amgen (Germany)","ror":"https://ror.org/02ezy5072","country_code":"DE","type":"company","lineage":["https://openalex.org/I1320553840","https://openalex.org/I4210121112"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Julia Stieglmaier","raw_affiliation_strings":["Amgen Research (Munich) GmbH, Munich, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Research (Munich) GmbH, Munich, Germany;","institution_ids":["https://openalex.org/I4210121112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108511133","display_name":"William Kevin Kelly","orcid":"https://orcid.org/0000-0003-2629-672X","observed_orcids":["https://orcid.org/0000-0003-2629-672X"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]},{"id":"https://openalex.org/I4210106595","display_name":"Sidney Kimmel Cancer Center","ror":"https://ror.org/010h6g454","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106595"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Kevin Kelly","raw_affiliation_strings":["Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA;","institution_ids":["https://openalex.org/I149251103","https://openalex.org/I4210106595"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":20,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"TPS5101","last_page":"TPS5101"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/steap1","display_name":"STEAP1","score":0.9490000009536743},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9200000166893005},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9210000038146973},{"id":"https://openalex.org/keywords/t-cell-mediated-lysis","display_name":"T cell-mediated lysis","score":0.5490000247955322},{"id":"https://openalex.org/keywords/novel-hormonal-therapy","display_name":"novel hormonal therapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7699999809265137},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8050000071525574},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7799999713897705},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.7319999933242798},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/psa-response","display_name":"PSA response","score":0.6320000290870667},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6330000162124634},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.7400000095367432},{"id":"https://openalex.org/keywords/first-in-human","display_name":"first-in-human","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9138860702514648},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.736873984336853},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7169831991195679},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7125717401504517},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6152513027191162},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5342183709144592},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4701668918132782},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4661724865436554},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.46208617091178894},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4274800419807434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4229111969470978},{"id":"https://openalex.org/C2778971682","wikidata":"https://www.wikidata.org/wiki/Q412963","display_name":"Cabazitaxel","level":5,"score":0.41672155261039734},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.33830147981643677},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.30283647775650024},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.23989617824554443}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.tps5101","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.tps5101","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3032409478","https://openalex.org/W4387797966","https://openalex.org/W3098747323","https://openalex.org/W3049208252","https://openalex.org/W4389280670","https://openalex.org/W3146712715","https://openalex.org/W4387810329","https://openalex.org/W3170211016","https://openalex.org/W4410809403","https://openalex.org/W4387798677"],"abstract_inverted_index":{"TPS5101":[0],"Background:":[1],"Six-transmembrane":[2],"epithelial":[3],"antigen":[4,284],"of":[5,14,55,99,133,138,167,227,298,308,315,327,344,346,363,406],"prostate":[6,15,66],"1":[7,117,248],"(STEAP1)":[8],"is":[9,28,118,377,398],"overexpressed":[10],"on":[11,23,40,47,203],"the":[12,44,92,104,110,171,204,213,225,328,402,423],"surface":[13],"cancer":[16,67],"cells":[17,42,49],"with":[18,80,84,124,148,153,195,230,242,300],"low":[19],"or":[20,215,234,324,333,339,364,368],"no":[21],"expression":[22],"normal":[24],"tissue.":[25],"AMG":[26,58,76,100,151,168,183,228],"509":[27,59,77,101,152,169,184,229],"a":[29,361],"bispecific":[30],"XmAb":[31],"2+1":[32],"T-cell":[33,52],"engager":[34],"that":[35],"simultaneously":[36],"binds":[37],"to":[38,102,128,140,247,305],"STEAP1":[39],"tumor":[41],"and":[43,89,97,126,198,209,245,261,265,269,288,311,360,389,397,411],"CD3":[45],"complex":[46],"T":[48],"resulting":[50],"in":[51,64,78,170,176,187,218,238,267,381,384,394,430],"mediated":[53],"lysis":[54],"STEAP1-expressing":[56],"cells.":[57],"demonstrated":[60],"significant":[61],"antitumor":[62],"activity":[63],"preclinical":[65],"models.":[68],"Methods:":[69],"This":[70],"4-part,":[71],"first-in-human":[72],"study":[73,392],"will":[74,90,163,181,199,223,419],"evaluate":[75,164,224],"pts":[79,121,142,189,239,400],"mCRPC":[81],"previously":[82,122,194,240],"treated":[83,123,193,241],"novel":[85],"hormonal":[86],"therapy":[87,338],"(NHT)":[88],"assess":[91],"safety,":[93,205],"tolerability,":[94],"pharmacokinetics":[95],"(PK),":[96],"efficacy":[98],"establish":[103],"maximum":[105],"tolerated":[106],"dose":[107,114,348,403],"(MTD)":[108],"and/or":[109,425],"recommended":[111],"phase":[112,405],"2":[113,129,162,410],"(RP2D).":[115],"Part":[116,161,177,179,219,221,407,417,431],"currently":[119],"enrolling":[120],"NHT":[125,197,244],"up":[127,139,246],"prior":[130,249],"taxanes.":[131],"As":[132],"31":[134],"January":[135,395],"2022,":[136],"60":[137],"110":[141],"have":[143,191,427],"been":[144,192,428],"enrolled":[145],"for":[146,251,401,415],"treatment":[147],"intravenous":[149],"(IV)":[150],"initial":[154],"inpatient":[155],"dosing":[156,166,186],"followed":[157],"by":[158],"outpatient":[159],"treatment.":[160],"subcutaneous":[165],"same":[172],"patient":[173],"population":[174],"as":[175],"1.":[178,220,432],"3":[180,418],"explore":[182],"IV":[185],"chemotherapy-na\u00efve":[188],"who":[190],"one":[196,243],"provide":[200],"additional":[201],"data":[202],"PK,":[206,277],"efficacy,":[207],"pharmacodynamics,":[208],"correlative":[210],"biomarkers":[211],"at":[212],"MTD":[214,424],"RP2D":[216,426],"determined":[217,429],"4":[222,342,412],"combination":[226],"abiraterone":[231],"(Part":[232,236],"4A)":[233],"enzalutamide":[235],"4B)":[237],"taxane":[250],"castration-sensitive":[252],"disease.":[253],"Primary":[254],"outcome":[255,274],"measures":[256,275],"include":[257,276],"dose-limiting":[258],"toxicities,":[259],"treatment-emergent":[260],"treatment-related":[262],"adverse":[263],"events,":[264],"change":[266],"clinical":[268],"laboratory":[270],"parameters.":[271],"Key":[272,291,317],"secondary":[273],"objective":[278],"response":[279],"per":[280],"RECIST":[281],"1.1,":[282],"prostate-specific":[283],"response,":[285],"progression-free":[286],"survival,":[287],"overall":[289],"survival.":[290],"inclusion":[292],"criteria":[293,319],"are":[294,320,413],"men":[295],"\u226518":[296],"years":[297],"age":[299],"pathologically":[301],"confirmed":[302],"mCRPC,":[303],"refractoriness":[304],"NHT,":[306],"evidence":[307],"progressive":[309],"disease,":[310,335],"ECOG":[312],"performance":[313],"status":[314],"0\u20131.":[316],"exclusion":[318],"pure":[321],"small":[322],"cell":[323],"neuroendocrine":[325],"carcinoma":[326],"prostate,":[329],"untreated":[330],"CNS":[331],"metastases":[332],"leptomeningeal":[334],"recent":[336],"anticancer":[337],"immunotherapy":[340],"within":[341],"weeks":[343],"start":[345],"first":[347],"not":[349],"including":[350],"luteinizing":[351],"hormone-releasing":[352],"hormone/gonadotropin-releasing":[353],"hormone":[354],"analogue":[355],"(agonist/antagonist)":[356],"therapy,":[357,359],"radiation":[358],"history":[362],"current":[365],"autoimmune":[366],"disease":[367,370],"any":[369],"requiring":[371],"chronic":[372],"immunosuppressive":[373],"therapy.":[374],"The":[375,391],"trial":[376,434],"being":[378],"carried":[379],"out":[380],"investigative":[382],"sites":[383],"North":[385],"America,":[386],"Australia,":[387],"Asia,":[388],"Europe.":[390],"opened":[393],"2020":[396],"recruiting":[399],"exploration":[404],"1;":[408],"parts":[409],"open":[414],"enrollment.":[416],"be":[420],"initiated":[421],"once":[422],"Clinical":[433],"information:":[435],"NCT04221542.":[436]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-06-12T00:00:00"}